Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-008202
Filing Date
2019-03-18
Accepted
2019-03-18 19:03:09
Documents
2
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4141
2 EX-24 DOCUMENT attachment1.htm EX-24 4147
  Complete submission text file 0000899243-19-008202.txt   9992
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROGESX INC. 981 INDUSTRIAL ROAD SUITE F SAN CARLOS CA 94070
Business Address
Ghiglieri Stephen F (Reporting) CIK: 0001394548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 19689765